Skip to content

Santa Monica Swim Center Extends Summer Recreational Swim Hours Starting June 23

Published:

By John Piacentini, Ph.D.

Most children and adolescents will be looking forward to exciting summer activities this month.

Many parents sign their youngsters up for day or overnight camps to keep them busy during the summer months. However, some youngsters are unable to go away to camps due to anxiety. Some youngsters worry that something bad may happen to him or his family if he is away from home. Other youngsters are extremely shy and become very nervous in social situations like camps. Thus, for some families, summertime can be stressful and anxiety-provoking, rather than a time of relaxation.

Research has shown that anxiety disorders are the most common type of psychiatric problem in children and adolescents with several studies suggesting a collective prevalence rate of 12 percent to 20 percent in this country.

Historically thought to be benign or developmentally normative, anxiety disorders can cause severe distress and lead to significant impairment in academic, social and familial functioning. Unfortunately, despite the fact that effective treatments exist for these children, only a small portion of clinically anxious youngsters ever receive appropriate and effective treatment for these symptoms. Research studies have shown both selective serotonin reuptake inhibitors (SSRIs) and cognitive behavior therapy (CBT) to be effective treatments for childhood anxiety disorders. However, these two treatments have never been directly compared to each other or their combination. The long-term advantages of one treatment compared to another have also not been studied.

The National Institute of Mental Health has recently funded a large multi-center study (Child and Adolescent Anxiety Multimodal Treatment Study, or CAMS) addressing these two issues. The Child OCD, Anxiety, and Tic Disorders Program at the UCLA Neuropsychiatric Institute and Hospital (UCLA-NPI) serves as the local site for this trial. Children and adolescents are eligible for the study if they are between 7 and 16 years old, medically healthy, off psychiatric medications and have a separation anxiety disorder, a generalized anxiety disorder or a social phobia.

All youngsters receive a comprehensive psychiatric evaluation to determine study eligibility. Eligible youngsters are then randomized to one of four treatment conditions: 1) sertraline, alone (Zoloft), 2) CBT, alone, 3) sertraline (Zoloft) plus CBT or, 4) pill placebo (sugar pill). Acute treatment lasts for 12 weeks. Responders to one of the three active treatment conditions receive an additional 24 weeks of the same treatment (meds, CBT, or both delivered during monthly clinic visits). Placebo nonresponders will be offered a free course of either CBT or medication, depending on their preference. All study assessments, visits, medications and therapy are provided free of charge.

For more information about the study, call Melody Keller at the UCLA Child Anxiety Program at (310) 825-4132. (John Piacentini, Ph.D. is associate professor-in-residence in the department of psychiatry and biobehavioral sciences at the UCLA School of Medicine and is director of the UCLA-NPI Child OCD, Anxiety and Tic Disorders Program.)

Originally published in the Santa Monica Daily Press print edition on June 17, 2003. Read the original PDF.

Comments

Sign in or become a SMDP member to join the conversation.

Sign in or Subscribe